Medical Professional Video Center

Home
Specialties
Refer a Patient
CME

Search Video Center

Refer Your Patient

Chapters

Transcript

Novel Theranostics-Focused Strategies for Optimizing Deployment of SSAs in Patients with Advanced and Metastatic GEP-NETs: The Role and Rationale for Use of Technology-Focused Strategies such as PRRT in the Multimodal Management Setting Michael Morse, MD

Published

September 20, 2016

Created by

PUBLISHED

September 20, 2016

HELPFUL LINKS

Request An Appointment
Make A Donation
Contact Us
About Mayo Clinic
Site Map

Any use of this site constitutes your agreement to the Terms and Conditions and Privacy Policy linked below.

Terms and Conditions
Privacy Policy
Notice of Privacy Practices

Mayo Clinic is a not-for-profit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products and services advertised.

Advertising and sponsorship policy
Advertising and sponsorship opportunities

A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.com," "EmbodyHealth," "Enhance your life," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.

Powered by BROADCASTMED
BroadcastMed Privacy Policy

Medical Professional Video Center

Novel Theranostics-Focused Strategies for Optimiz­ing Deployment of SSAs in Patients with Advanced and Metastatic GEP-NETs: The Role and Rationale for Use of Technology-Focused Strategies such as PRRT in the Multimodal Management Setting Michael Morse, MD

Novel Theranostics-Focused Strategies for Optimizing Deployment of SSAs in Patients with Advanced and Metastatic GEP-NETs: The Role and Rationale for Use of Technology-Focused Strategies such as PRRT in the Multimodal Management Setting Michael Morse, MD